Kanazawa University research: High-speed AFM imaging reveals how brain enzyme forms dodecameric ring structure 
Meridian Bioscience Reports Third Quarter Fiscal 2021 Results
CINCINNATI, Aug. 06, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) today announced financial results for the third quarter...
Aquestive Therapeutics to Participate in 12th Annual Wedbush PacGrow Healthcare Virtual Conference
WARREN, N.J., Aug. 06, 2021 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical company focused on developing and...
Replimune Reports Fiscal First Quarter Financial Results and Provides Corporate Update
Updated complete and durable response data in RP1 (vusolimogene oderparepvec) skin cancer cohorts support the ongoing registration directed development programs...
10x Genomics to Present at the UBS Genomics 2.0 and MedTech Innovations Summit
PLEASANTON, Calif., Aug. 06, 2021 (GLOBE NEWSWIRE) -- 10x Genomics, Inc. (Nasdaq: TXG), today announced the company will be participating...
President & CEO of Nova Leap Health Corp. to Present at the Q3 Virtual Investor Summit
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HALIFAX, Nova Scotia, Aug. 06, 2021...
Cronos Group Appoints Bob Madore as Chief Financial Officer
TORONTO, Aug. 06, 2021 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”), an...
Ocugen Provides Business Update and Second Quarter 2021 Financial Results
Conference Call and Webcast Today at 8:30 a.m. ET Rolling regulatory submission to Health Canada completed and...
Kaleido Biosciences to Participate in the 41st Annual Canaccord Genuity Growth Conference
LEXINGTON, Mass., Aug. 06, 2021 (GLOBE NEWSWIRE) -- Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage healthcare company with a differentiated,...
Ocuphire Pharma Presenting at Two Conferences in August
Canaccord Genuity 41st Annual Growth Conference being held virtually on August 10-12, 2021 HC Wainwright Ophthalmology Virtual Conference on August...
InflaRx to Present at the BTIG Virtual Biotechnology Conference
JENA, Germany, Aug. 06, 2021 (GLOBE NEWSWIRE) -- InflaRx (Nasdaq: IFRX), a clinical-stage biopharmaceutical company developing anti-inflammatory therapeutics by targeting...
Cronos Group Reports 2021 Second Quarter Results
Amended agreement with Ginkgo Bioworks to accelerate commercialization of cultured cannabinoids Announced strategic investment in PharmaCann, a leading U.S. cannabis...
Ascendis Pharma A/S Announces Upcoming Investor Presentations in August
COPENHAGEN, Denmark, Aug. 06, 2021 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative...
Chairman of GKSD, Kamel Ghribi, provides medical support to Algeria by donating equipment to support the fight against the COVID pandemic
GKSD responded to a call for assistance from His Excellency Ahmed Boutache the Ambassador of Algeria to Italy, with 12...
Amryt Reports Record Q2 2021 Results and Raises FY 2021 Guidance
Amryt Reports Record Q2 2021 Results and Raises FY 2021 Guidance Acquisition of Chiasma completed Amryt now has three approved...
Nunzia Pharmaceutical Corporation (OTC:NUNZ), an Emerging Leader in Innovative Pharmaceutical and Nutraceuticals, has Signed a Licensing Agreement with Michael Mitsunaga for the Exclusive Patent Rights to his IV BLOOD WARMER
SAN CLEMENTE, CA, Aug. 06, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Nunzi Pharmaceutical Corporation (OTC:NUNZ) entered into a License...
ASLAN Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Corporate Update
Recruitment completed in June for the expansion cohort of the Multiple Ascending Dose (MAD) trial of ASLAN004, underway for the...
Iterum Therapeutics to Provide Business Update and Report Second Quarter 2021 Financial Results on August 13, 2021
DUBLIN, Ireland and CHICAGO, Aug. 06, 2021 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (the Company), a clinical-stage pharmaceutical...
Bio-Path Holdings to Announce Second Quarter 2021 Financial Results on August 13, 2021
HOUSTON, Aug. 06, 2021 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc. (NASDAQ: BPTH), a biotechnology company leveraging its proprietary DNAbilize® antisense...
Imara Reports Second Quarter 2021 Financial Results and Business Highlights
Accelerated enrollment in Phase 2b trials in sickle cell disease and beta-thalassemia; interim analyses expected in fourth quarter of 2021...
Kymera Therapeutics Announces Second Quarter 2021 Financial Results and Provides a Business Update
Positive interim results from Single Ascending Dose portion of Phase 1 trial of first-in-class oral IRAK4 degrader KT-474 demonstrated degrader...